Won-Yoon Chung Selected Research

Won-Yoon Chung Research Topics

Disease

40	Neoplasms (Cancer) 05/2022 - 08/2002
13	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2009
11	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2005
11	Squamous Cell Carcinoma of Head and Neck 01/2021 - 04/2007
9	Bone Resorption 04/2020 - 07/2010
5	Mouth Neoplasms (Oral Cancer) 01/2021 - 04/2007
5	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 01/2006
5	Edema (Dropsy) 09/2014 - 08/2002
4	Osteolysis 01/2018 - 01/2015
4	Carcinogenesis 04/2013 - 01/2002
4	Inflammation (Inflammations) 01/2010 - 01/2002
3	Body Weight (Weight, Body) 03/2017 - 06/2008
3	Osteoporosis 01/2015 - 09/2012
3	Colonic Neoplasms (Colon Cancer) 09/2014 - 11/2009
3	Carcinoma (Carcinomatosis) 07/2011 - 01/2010
3	Arthritis (Polyarthritis) 01/2010 - 01/2010
3	Experimental Arthritis 01/2010 - 01/2010
3	Papilloma (Papillomatosis) 01/2006 - 08/2002
2	Hemorrhage 05/2022 - 01/2021
2	Periodontitis 12/2018 - 11/2004
2	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2015
2	Postmenopausal Osteoporosis 01/2018 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2017 - 03/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2013 - 05/2009
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Triple Negative Breast Neoplasms 01/2017

Drug/Important Bio-Agent (IBA)

6	Matrix Metalloproteinases (MMPs)IBA 04/2020 - 07/2009
6	Messenger RNA (mRNA)IBA 01/2018 - 09/2012
6	isoliquiritigenin (GU 17)IBA 12/2015 - 01/2006
6	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2013 - 08/2002
5	xanthorrhizolIBA 01/2021 - 05/2004
5	anthraceneIBA 09/2014 - 02/2005
5	Cisplatin (Platino)FDA LinkGeneric 07/2012 - 05/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2006
4	CytokinesIBA 01/2021 - 07/2008
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2008
4	Parathyroid Hormone-Related ProteinIBA 02/2017 - 02/2014
4	RANK LigandIBA 01/2017 - 03/2014
4	SaponinsIBA 01/2015 - 01/2010
4	NF-kappa B (NF-kB)IBA 07/2009 - 03/2004
3	buddlejasaponin IVIBA 01/2023 - 10/2011
3	OsteoprotegerinIBA 04/2020 - 12/2015
3	LigandsIBA 04/2020 - 12/2013
3	Methanol (Carbinol)IBA 01/2017 - 01/2010
3	TriterpenesIBA 01/2015 - 12/2013
3	SesquiterpenesIBA 04/2013 - 01/2005
3	Phorbol EstersIBA 01/2010 - 08/2002
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2009 - 08/2002
3	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 07/2008 - 08/2002
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2022 - 01/2021
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2022 - 01/2021
2	Interleukin-8 (Interleukin 8)IBA 01/2022 - 01/2012
2	platycodin DIBA 01/2022 - 01/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 03/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 04/2020
2	Conditioned Culture MediaIBA 04/2020 - 12/2013
2	Cathepsin KIBA 04/2020 - 12/2012
2	artemisinin (artemisinine)IBA 01/2018 - 01/2011
2	ChemokinesIBA 01/2017 - 12/2015
2	Transforming Growth Factor beta (TGF-beta)IBA 07/2014 - 11/2012
2	lysophosphatidic acidIBA 03/2014 - 01/2012
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 11/2012 - 09/2012
2	ErbB Receptors (EGF Receptor)IBA 04/2012 - 01/2006
2	kalopanax saponin AIBA 01/2012 - 07/2009
2	Tissue Inhibitor of Metalloproteinase-1IBA 01/2012 - 07/2009
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2012 - 07/2009
2	phorbolIBA 01/2012 - 07/2009
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2012 - 07/2009
2	decursinIBA 07/2011 - 07/2009
2	Collagen Type II (Type II Collagen)IBA 01/2010 - 01/2010
2	FlavonoidsIBA 05/2009 - 01/2006
2	CarcinogensIBA 04/2007 - 02/2005
2	EnzymesIBA 04/2007 - 11/2004
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 04/2007 - 11/2004
2	Transcription Factors (Transcription Factor)IBA 02/2005 - 08/2002
1	IntegrinsIBA 05/2022
1	Chemokine CX3CL1IBA 01/2021
1	C-Type Lectins (C-Type Lectin)IBA 01/2021
1	CollagenIBA 01/2021
1	Insulin-Like PeptidesIBA 04/2020
1	CateninsIBA 04/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2020
1	Cadherins (E-Cadherin)IBA 04/2020
1	VimentinIBA 04/2020
1	Activating Transcription Factor 3IBA 01/2018
1	E2F Transcription FactorsIBA 01/2018
1	SmokeIBA 03/2017
1	Nicotine FDA Link 03/2017
1	Biomarkers (Surrogate Marker)IBA 02/2017
1	AntibodiesIBA 01/2017
1	liensinineIBA 01/2017
1	nuciferineIBA 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017
1	AntigensIBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017

Therapy/Procedure

10	Oral Administration 01/2017 - 07/2009
5	Therapeutics 01/2019 - 05/2004
1	Traditional Medicine (Folk Remedies) 12/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	East Asian Traditional Medicine (Oriental Medicine) 06/2016